Compare CC & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CC | CLOV |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.3B |
| IPO Year | N/A | N/A |
| Metric | CC | CLOV |
|---|---|---|
| Price | $12.94 | $2.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $17.00 | $4.23 |
| AVG Volume (30 Days) | 2.4M | ★ 4.4M |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | ★ 2.70% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,837,000,000.00 | $1,773,564,000.00 |
| Revenue This Year | $3.34 | $41.68 |
| Revenue Next Year | $4.20 | $37.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.03 | ★ 32.15 |
| 52 Week Low | $9.13 | $2.12 |
| 52 Week High | $20.12 | $4.87 |
| Indicator | CC | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 53.81 |
| Support Level | $12.09 | $2.41 |
| Resistance Level | $13.42 | $2.80 |
| Average True Range (ATR) | 0.62 | 0.10 |
| MACD | 0.17 | 0.05 |
| Stochastic Oscillator | 81.64 | 83.50 |
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.